News
-
-
-
COMMUNIQUÉ DE PRESSE
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
-
COMMUNIQUÉ DE PRESSE
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
-
COMMUNIQUÉ DE PRESSE
SIP Purchase, PDMR and Total Voting Rights
-
COMMUNIQUÉ DE PRESSE
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
-
COMMUNIQUÉ DE PRESSE
Samarkand Group plc : Director Dealings
-
-
-